MicroRNA-218 is upregulated in gastric cancer after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy and increases chemosensitivity to cisplatin

Table 1 Clinical background of 5 patients with advanced gastric cancer

Age	Sex	TNM stage	Histology of tumor	Drug regimen of HIPEC	Duration of HIPEC (min)	ECOG	HIPEC temperature (°C)	Time of surgery (h)	Following time (yr) and results
49	Male	T4aN1M0	Poorly-differentiated adenocarcinoma	5-Fu cisplatin	60	1	43	3	1, alive
56	Male	T3N2M0	Moderately-differentiated adenocarcinoma	5-Fu cisplatin	60	2	43	3.5	1.5, alive
67	Female	T4N2M0	Poorly-differentiated adenocarcinoma	5-Fu cisplatin	60	0	43	3.8	1, dead
53	Male	T3N1M0	Poorly-differentiated adenocarcinoma	5-Fu cisplatin	60	1	43	4	1.2, dead
62	Male	T4bN0M0	Moderately-differentiated adenocarcinoma	5-Fu cisplatin	60	2	43	3	0.5, alive

ECOG: Eastern Cooperative Oncology Group; HIPEC: Hyperthermic intraperitoneal chemotherapy.